April 22, 2009

The Future of Dendreon

Seeking Alpha has a lengthy article discussing the future prospects of Dendreon that is primarily being fueled by Provenge, the first cancer drug that will be approved by the FDA. There is tremendous upside for the drug and the stock, but investors should proceed with caution, as the author makes a couple of wild projections as he estimates the future value of the shares.

No comments: